Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint–Based Therapy in Patients With Advanced NSCLC
15.4.2021
0:00
15:06
Interview with Charu Aggarwal, MD, and Lova Sun, MD, authors of Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
Flere episoder fra "JAMA Oncology Author Interviews"
Gå ikke glip af nogen episoder af “JAMA Oncology Author Interviews” - abonnér på podcasten med gratisapp GetPodcast.